INCR vs. ATNFW, LBPSW, AIMDW, ALVOW, ACABW, BFRIW, BTMDW, BCTXW, CALA, and CELUW
Should you be buying InterCure stock or one of its competitors? The main competitors of InterCure include 180 Life Sciences (ATNFW), 4D pharma (LBPSW), Ainos (AIMDW), Alvotech (ALVOW), Atlantic Coastal Acquisition Corp. II (ACABW), Biofrontera (BFRIW), biote (BTMDW), BriaCell Therapeutics (BCTXW), Calithera Biosciences (CALA), and Celularity (CELUW). These companies are all part of the "pharmaceutical products" industry.
InterCure vs. Its Competitors
InterCure (NASDAQ:INCR) and 180 Life Sciences (NASDAQ:ATNFW) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, dividends, valuation, analyst recommendations, media sentiment, earnings, profitability and institutional ownership.
180 Life Sciences has lower revenue, but higher earnings than InterCure.
In the previous week, InterCure had 1 more articles in the media than 180 Life Sciences. MarketBeat recorded 1 mentions for InterCure and 0 mentions for 180 Life Sciences. InterCure's average media sentiment score of 0.80 beat 180 Life Sciences' score of 0.00 indicating that InterCure is being referred to more favorably in the media.
8.3% of InterCure shares are held by institutional investors. 0.2% of InterCure shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.
Summary
InterCure beats 180 Life Sciences on 6 of the 6 factors compared between the two stocks.
Get InterCure News Delivered to You Automatically
Sign up to receive the latest news and ratings for INCR and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding INCR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
InterCure Competitors List
Related Companies and Tools
This page (NASDAQ:INCR) was last updated on 10/16/2025 by MarketBeat.com Staff
